Received: 18 March 2020
Accepted: 3 September 2020
First Online: 2 October 2020
Ethics approval and consent to participate
: Institutional ethical committee approval number IRB0004025 was obtained from Institutional Review Board of National Cancer Institute, Cairo University (IRB-NCI) on December 11, 2018, Organization no: IORG0003381. Then the paper obtained trial registry number PACTR201812842421823 from Pan African clinical trial registry. A written informed consent was obtained from each participating patient.
: Not applicable.
: The authors declare that they have no competing interests.